Startpage
 

Contact

 

25-03-2006
Low Frequency
hearing Losses in
Endolymphatic Hydrops

25-03-2006
Endolymphatic
Hydrops

05-02-2006
Question 02/2006

 

 

Topic of the month

25-03-2006 (back to top)

Low Frequency Hearing Losses in Endolymphatic Hydrops.

by Søren Vesterhauge MD DMSc, Consultant, The Private Hospital Hamlet, Copenhagen.

The fluid filled inner ear is surrounded by bone except at the two windows, the round and the oval windows, which are both vital for the mechanical transmission of sound waves from the ear canal through the middle ear to the inner ear. The outer fluid of the inner ear (yellow in the figure below), the perilymphatic fluid, mainly communicates with the fluid surrounding the brain and the spinal cord (the cerebrospinal fluid = CSF) through a tiny canal, the cochlear aqueduct. The inner fluid compartment, the endolymphatic space (blue in the figure below), has no direct communication with the CSF, but a small sac (the endolymphatic sac) is placed between the membrane surrounding the brain (dura mater) and the bone surrounding the inner ear (the petrous part of the temporal bone). This sac connects to the perilymphatic space through a canal in another tiny bony canal, the endolymphatic duct. The pressure of the CSF changes with the position of your body and with the changes in pressure of the veins of the brain. So when it happens, it is important that the pressure alteration in the perilymphatic fluid compares to those pressure alterations of the endolympatic fluid. If not, it will result in a tension of the membrane between the two spaces, the endolymphatic membrane. In the normal ear there is a balance of the impedances (resistances) of the connections between the two compartments of the inner ear on one side and the CSF on the other side.

Figure 1. Model of the inner ear fluid compartments.
Yellow is the perilymphatic space and blue is the endolymphatic space.

Further the production of endolymph in the inner ear must be at a size of order that it doesn’t cause any increase or decrease of the endolymphatic pressure and the two windows of the inner ear to the middle ear must be water tight, so that a loss of perilymph to the middle ear will not cause any pressure changes of the inner ear. Under these circumstances of balances pressures of the two inner ear compartment, the endolymphatic membrane will neither distend nor collapse. This is vital for the function of the inner ear sensory organs for hearing and balance.

In some ears this balance of pressures is disrupted, could be because of a perilymph leak to the middle ear, a high production of endolymph or a loss of balance of the pressure transmission from the CSF to the two separate inner ear compartments – or for reasons we simply don’t know.

We don’t know much about collapses of the endolymphatic system, but we know for sure that a distension of the endolymphatic membrane = an endolymphatic hydrops is a common cause of inner ear malfunction. It is probably seen in all cases of Menière’s disease but also in lot patients never attacked by vertigo. In those patients, a low frequency hearing loss is common as it is in Menière’s disease. Some of these patients also complain of tinnitus and some of a feeling of fullness of the ear (a feeling of pressure, sometimes painful). The German-American audiologist, Juergen Tonndorf, has provided a beautiful mechanical explanation for that, showing that a pressure load to the cochlea will have a greater impact on the apical parts of the cochlea than on the basal parts. And we know that the apical part is responsible for the low frequency hearing function.

There is no single efficient treatment, probably because there is no single common mechanism behind different cases of hydrops. In some cases diuretic drugs and salt restrictions (Fuerstenberg diet) are efficient and in other case (e.g. perilymphatic leaks) they are not. In some cases a vent tube in the ear drum in association with a pressure pulse treatment (Meniett®) will improve the condition; in the case of a perilymphatic leak it will have the opposite effect. Some drugs, which are not available in all countries, (Vastarel® (trimethazidine) and Serc (betahistine)) may be helpful for the patient. And in some other cases the condition normalizes by itself, as mysteriously as it appeared.

 

25-03-2006
ENDOLYMPHATIC HYDROPS (back to top)

Carlos Herraiz, M.D. PhD
Tinnitus Clinic. Instituto ORL Antolí-Candela, Madrid. Spain
Tinnitus Clinic. ENT Department. Fundación Hospital Alcorcón, Madrid. Spain

The endolymphatic hydrops (EH) is a histopathological condition of the inner ear with clinical manifestations in some patients. A disorder of the metabolism of endolymph and perilymph is the responsible of the atrophy of the labyrinth. Patients can show a fluctuating and progressive sensorineural hearing loss (SNHL), tinnitus, aural pressure, vertigo or unsteadiness. The presence of all these symptoms in the same patient describes the Mèniere’s Disease (MD).

Pathophysiology
The unbalance between endolymph production and release is the responsible of an increase in the pressure of the endolymph canal. Possible mechanisms described are the excess in endolymph production form the grey cells and the stria vascularis cells or a failure in the release at the endolymphatic sac. It can affect exclusively the anterior labyrinth, the posterior labyrinth or both. The high pressure causes a rupture of the membranes, increasing the potassium concentration in the perilymph. This fact causes a reduction in activation of the neuronal dendrites, responsible of the clinical symptoms.

Clinical course
The manifestation and course of EH symptoms is extremely variable. Some patients present a tinnitus in the affected ear years before the development of hearing loss or vertigo. In other patients, vertigo is the isolated symptom and hearing loss appears afterwards. The clinical characteristics of EH are:

Fluctuate and progressive SNHL The first step of cochlear disruption comes from the acute increase in endolymph pressure. This mechanism causes two effects: a reduction of the movement of the stapes that provokes a conductive hearing loss, and second, displacement of the basilar and Reissner membranes that causes a sensorineural hearing loss in the low and medium frequencies. Initially, these changes are reversible and hearing improves after the acute crisis. The patient show a fluctuating hearing loss.
The maintenance of higher-pressure levels in the labyrinth could be responsible of the atrophy of the hair cells and the organ of Corti. The outer hair cells (OHC) are more sensible and they are the first impaired due to this mechanism. The patient will show a decrease in hearing thresholds and selective sound discrimination. When the EH progresses, the inner hair cells (IHC) are affected and hearing thresholds are worse. A phenomenon of “recruitment” is common in EH patients. An increase in the acoustic stimulus provokes a sudden and intense sensation of sound that can cause a terribly annoyance. This effect is related with the impairment of OHC.

Distortion in sound perception and diplacusis are also described by the patients.

Tinnitus
Tinnitus is a common symptom in cochlear EH and Ménière’s disease (MD) patients.It can be the first symptom even years before to the appearance of hearing loss or vertigo. It is usually described as the sound of the ocean or a conch (low or medium frequencies) although it can be a buzzing sound too. Tinnitus loudness increases after external sound exposition, changes in the atmospheric pressure, anxiety and vertigo spells. Severity is influenced by the longer duration of the disease, the bilateral affection, hearing impairment or hyperacusis.

Aural pressure
An increased pressure in the affected ear is commonly described by the patients. This condition is especially intense during the acute crisis.

Hyperacusis
Decreased sound tolerance is commonly associated to EH. It is a chronic situation but it can be increased during the acute cochlear crisis (increase of tinnitus, hearing loss and aural pressure) or during the vertigo spells. More than 70% of the MD’s patients in a tinnitus clinic show a pathological decrease in loudness discomfort levels. Many EH patients avoid noisy places and some of them show an important affection in their quality of life if no specific treatment is carried out.

Vertigo and unsteadiness
Vertigo spells are the most characteristic symptom of vestibular EH and MD. Patients refer a spin sensation that can last minutes to days. The presence of nausea, sickness, cold sweat is common during the attack. After the acute spell, the patients refer unsteadiness that can last weeks, specially towards the affected side. Frequency of vertigo is highly heterogeneous, from almost a vertigo spell a day to one crisis in years. Seventeen percent of MD’s patients present drop attacks: sudden fall without any previous sensation, commonly aggravated by cranial-encephalic trauma.

Clinical entities related with EH
Ménière’s Disease (MD): The American Academy of Otolaryngology –HNS defines the MD as an idiopathic disease (unknown aetiology), clinically described as recurrent vertigo attacks (more than 20 minutes), sensorineural hearing loss, aural pressure and tinnitus. The prevalence is 46 cases / 100 000 habitants and incidence is 4.3 /100 000 hab / year. Women are slightly more affected than men, and it starts between 35 and 50 years old approximately. Between 9 and 47% of the patients refer a binaural disease, according to different series. Fourteen percent of the cases have been related to mutations on the chromosome 7.
Allergies, migraines, stress or anxiety, menopause, menstruation, non-hyposodical diets are factors that can exacerbate the crisis.

The MD requires the presence of the four symptoms to be diagnosed. We can find atypical manifestations of the disease that includes only some of these symptoms. Cochlear EH is a clinical entity where patients refer the presence of fluctuate or progressive SNHL, tinnitus and/or aural pressure. These symptoms can appear simultaneously or can be developed over the time.
Vestibular EH shows recurrent vertigo attacks, unsteadiness or drop-attacks without auditory findings.

Delayed EH (non-idiopathic)
Some systemic or ear diseases can provoke an EH when they progress over the time. Syphilis (a sexual transmitted infection), the Paget Disease (alteration of the bone metabolism), otosclerosis (stapes fixation by new bone formation) and the inner ear auto-immunological disease are responsible of EH histopathology and clinical symptoms.

Diseases with MD-like symptoms but without histopathological EH
There are a group of diseases that present similar symptoms as the ones described for MD (tinnitus, fluctuate SNHL, vertigo, aural pressure) but there are not histological findings for EH. These entities are: dilated vestibular aqueduct syndrome, basilar artery migraine, VIII cranial nerve vascular compression syndrome, benign intracranial hyper-pressure, acoustic tumors or esclerosis multiple

Diagnosis
Due the two clinical components of the EH (auditory and vestibular), the diagnosis protocol includes a battery test for both structures.

Auditory evaluation requires a complete study of hearing. Tonal audiometry, speech audiometry, timpanometry and the study of the stapedial reflex (cochlear recruitment) are mandatory. The otoacoustic emissions (transitory and distortion products) are sometimes the first affected test, even when a hearing loss cannot be achieved with the audiometry test. The study of auditory evoked potentials is necessary to rule out a VIII cranial nerve or central auditory pathway affection. The electrocochleography is less used but it can also be affected in the first steps of the disease. The glycerol test (an osmotic substance that reduces the labyrinth pressure and increases hearing sensation) can be used to confirm a MD disease but when it is negative, it does not rule out this disease.

Vestibular evaluation requires a study of the responses after a vestibular stimulation. The videonystagmography is used to detect spontaneous nystagmus that commonly appears during an acute attack. The rotational test and the caloric testing can reflect a reduction in the function and reflectivity of the affected labyrinth. The dynamic posturography is a test that measures the balance of the patient when different conditions are applied (eyes closed, platform movement and changes in the visual environment). It is typically affected in the chronic vestibular EH or MD. Worse results are obtained when bilateral disease.

Imaging. Although EH or MD does not show typical findings in the magnetic resonance, this test is mandatory to rule out other important diseases that affect the central nervous system (tumours, vascular diseases, esclerosis multiple, etc.)

Treatment
There is not any curative and definitive treatment for EH or MD, but symptoms can be more or less successfully controlled considering some factors:
Low sodium diet has demonstrated a reduction in vertigo spells over the time.
Anxiety and stress are commonly involved in the appearance of the crisis. An acceptable control of psycho-emotional symptoms could reduce the presence of acute manifestations of the disease.
Drugs. In our experience, corticosteroids are a useful drug for about 50% of MD’s patients when fluctuate SNHL or acute intensification of tinnitus loudness.
The use of betahistine, trymetazidine, antihistaminic drugs, cinarizine or sulpiride helps some patients during the vertigo attacks. The benzodiadepines can also control an intense vertigo spell.
Diuretics are a useful treatment for chronic manifestations of EH / MD and maybe they can reduce the number or exacerbations of the disease.
The use of antidepressants in patients with depression (due to or not related to MD) could be useful to reduce anxiety and the possibility of acute crisis.
Intratympanic delivery of drugs. The use of the intratympanic delivery is spreading nowadays among the ENT teams. High dosage of the drug is delivered to the inner ear through the round window perfusion with almost any systemic adverse effect. Intratympanic corticosteroids are commonly used by our team when a positive response has been achieved with oral corticosteroids, and they have been effective to control the cochlear symptoms in some patients (tinnitus, hearing loss, aural pressure). The use of gentamicine (antibiotic with an ototoxic effect) for a chemical labyrinthectomy has achieved the elimination of the vertigo spells in almost 80% of the patients. A high risk of hearing loss increase is documented when using this substance. Tinnitus retraining therapy. In a recent publication of our team, TRT is an effective treatment for tinnitus habituation in MD’s patients. The use of hearing aids has demonstrated better results in tinnitus control when compared with patients that refused hearing aid fitting.
Surgery. Endolymphatic sac surgery is a non-destructive procedure that reduces vertigo spells in 60% of the cases according to different studies. Vestibular neurectomy,a destructive procedure, resolves vertigo in more than 95% of the patients. If there is a severe or profound hearing loss, we can perform a surgical labyrinthectomy that achieves a similar percentage for the elimination of vertigo but with a complete hearing loss. Tinnitus can improve in 60% of the patients but an intense increase in tinnitus loudness has also been described.
Vestibular rehabilitation. The use of the dynamic posturography has demonstrated an improvement of unsteadiness after surgery (neurectomy or labyrinthtectomy). Dizziness secondary to bilateral disease can also get profit from this technique of rehabilitation.

Prognosis
The clinical course of the EH / MD is highly heterogeneous and it is difficult to make a prognosis respect to the the disease. The results that we show are average statistics of the population. That means that we have to consider as well, the extremes of the sample: some patients did not show an increase of the symptoms (the disease does not progress, hearing loss is mild, tinnitus is not present or is absolutely habituated and there is not any vertigo spell). But in other patients, the clinical course is faster and more aggressive. They will require more intense treatments. ).
According to some authors, 82% of the patients show 50% impairment of the hearing loss after 20 years of the disease. Tinnitus increases if longer course of the disease or worse hearing loss, but we can get an aceptable control in tinnitus habituation when we use drugs (corticosteroids) or sound therapies (TRT). The number of vertigo spells reduces if longer period of the disease. Unsteadiness is commonly present at the end of the EM.

Recommended references

Antoli-Candela F, Tapia MC. Hydrops endolinfático.
Suplementos de Actualización en ORL 2005;1:27-37

Herraiz C, Tapia MC, Plaza G. Tinnitus and Ménière’s disease: characteristics and prognosis in a tinnitus clinic simple. Eur Arch Oto Rhino Laryngol (in press, march 2006)

Herraiz C, Plaza G, De los Santos G. Tinnitus retraining therapy in Ménière disease. Acta Otorrinolaringol Esp 2006;57:96-100

Herraiz C, Hernandez FJ, Plaza G, De los Santos G. Long-Term Clinical Trial of Tinitus Retraining Therapy. Otolaryngol Head Neck Surg 2005;133:774-779

Committeee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease (1995). American Academy of Otolaryngology-Head Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 113: 181-5

Hagnebo C, Melin L, Larsen HC et al (1997). The influence of Vertigo, Hearing Impairment and Tinnitus on the Daily Life of Meniere Patients. Scand Audiol 26: 69-76

Havia M, Kentala E, Pyykkö I (2002). Hearing loss and tinnitus in Meniere’s disease. Auris Nasus Larynx 29: 115-119

Yardley L, Dibb B, Osborne G (2003). Factors associated with quality of life in Ménière’s disease. Clin Otolaryngol 28: 436-441

Sajjadi H. Medical management of Meniere's disease. Otolaryngol Clin North Am. 2002 Jun;35(3):581-9

Barrs DM, Keyser JS, Stallworth C et al. Intratympanic steroid injections for intractable Ménière’s Disease. Laryngoscope 2001;111:2100-2104

Herraiz C, Hernández Calvín J, Toledano A, et al. Corticoid therapy for tinnitus patients. En Proceedings of the VII International Tinnitus Seminar, Patuzzi R ed. Perth, Australia 2002:pag 86-88

 

05-02-2006
Question of February: (back to top)

In order to increase information and to inform members (as well as professionals) about tinnitus and related problems we would like to discuss a specific “question of the month”. The question this month is about low pitch hearing loss (so called “hydrops”) and related low pitch tinnitus (humming), a problem often seen at the beginning of Mobus Meniere Disease but also as an isolated symptom without vertigo.

We would like you to deliver the expert´s opinions about pathophysiology, the treatment and your experiences regarding this problem.

 

Answer by Dr. Birgit Mazurek

In our experience the diagnosis of Meniere's disease is considered in all patients showing all of the three symptoms hearing loss, tinnitus and vertigo.
Regarding pathophysiology, Reissner's membrane develops lesions in single cells or in groups of cells in its epithelial layer.
These lesions might on one hand modify the electro-chemical environment of the organ of Corti - a condition that could cause an endolyphatic hydrops displaying mere hearing loss or tinnitus.
On the other hand swelling and increasing pressure of the membranous labyrinth due to the accumulation of ions seeping though the lesions might also cause distension or even rupture of Reissner's membrane.
In these cases, patients would develop vertigo as an additional symptom. As therapy, we suggest the following recommendations: 1. no alcohol and caffeine, maximum drinking amount of 2 liters per 24 hours 2. betahistine therapy, if nausea occurs, symptomatic treatment with dimenhydrinate, 3 in cases of low pitch hearing loss infusion therapy and cortisol could be helpful 4.
in severe cases administration of picrototoxin 5. in cases resistent to other therpeutic approaches destruction of the inner ear by transtympanic administrasion of aminoglycsides

DR. Birgit Mazurek University of Berlin

 

Answer by Hans-Peter Zenner, MD, PhD

Low-frequency hearing loss is often attributed to an endolymphatic hydrops. A working model to explain an endolymphatic hydrops is a resorption problem of the endolymph in the endolymphatic sac. Because an important mechanism for endolympathic resorption is the function of aquaporines, it is an elegant hypothesis to think that a dysfunction of aquaporines may play a role in the production of endolympathic hydrops. On the other hand, a production problem of the endolymph in the stria vascularis may also be an underlying mechanism.
Based on the assumption of endolympathic hydrops, a good approach is to perform a Klockhoff-test (oral application of glycerol). In case of immediate hearing improvement this is followed by intravenous and oral osmotherapy. In case there is no positive Klockhoff-test, it is a good model to anticipate, that apoptosis may play a role in the pathophysiological problem. Thus, the application of alphaliponic acid is supported by this model.

Hans-Peter Zenner, MD, PhD

 


Sponsors





-------------------

General Info
(in English, German and French)

Tinnitus
Tinnitus is a problem of a great number of people...
(click here and read all)

Hyperacusis
More information about Hyperacusis will be presented soon....
(click here and read all)

Hearing Loss

Hearing loss is something that happens...
(click here and read all)

Meniéres disease
Menière’s disease is precisely describ...
(click here and read all)

Sudden deafness More information about Sudden deafness will be presented soon...
(click here and read all)

Psychological disorders combined with tinnitus
More information about Psychological disorders combined with tinnitus will be pr...
(click here and read all)

 

©EUTi 2007